StemCell Institute Future Growth
Future criteria checks 6/6
StemCell Institute is forecast to grow earnings and revenue by 38.4% and 26.1% per annum respectively. EPS is expected to grow by 38.3% per annum. Return on equity is forecast to be 25.5% in 3 years.
Key information
38.4%
Earnings growth rate
38.3%
EPS growth rate
| Healthcare earnings growth | 9.7% |
| Revenue growth rate | 26.1% |
| Future return on equity | 25.5% |
| Analyst coverage | Low |
| Last updated | 15 Aug 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 5,200 | 1,150 | N/A | N/A | 1 |
| 3/31/2026 | 4,000 | 780 | N/A | N/A | 1 |
| 3/31/2025 | 3,000 | 500 | N/A | N/A | 1 |
| 6/30/2024 | 2,582 | 413 | N/A | N/A | N/A |
| 3/31/2024 | 2,481 | 310 | 133 | 334 | N/A |
| 12/31/2023 | 2,396 | 280 | N/A | N/A | N/A |
| 9/30/2023 | 2,268 | 247 | 40 | 190 | N/A |
| 6/30/2023 | 2,176 | 223 | N/A | N/A | N/A |
| 3/31/2023 | 2,091 | 198 | 40 | 99 | N/A |
| 12/31/2022 | 2,044 | 208 | N/A | N/A | N/A |
| 9/30/2022 | 1,952 | 183 | 176 | 270 | N/A |
| 6/30/2022 | 1,849 | 160 | N/A | N/A | N/A |
| 3/31/2022 | 1,781 | 133 | 265 | 469 | N/A |
| 12/31/2021 | 1,661 | 99 | N/A | N/A | N/A |
| 3/31/2021 | 1,409 | 62 | -165 | 238 | N/A |
| 12/31/2020 | 1,470 | 123 | N/A | N/A | N/A |
| 3/31/2020 | 1,676 | 277 | N/A | N/A | N/A |
| 3/31/2019 | 1,149 | 142 | N/A | N/A | N/A |
| 3/31/2018 | 861 | 69 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7096's forecast earnings growth (38.4% per year) is above the savings rate (0.3%).
Earnings vs Market: 7096's earnings (38.4% per year) are forecast to grow faster than the JP market (8.6% per year).
High Growth Earnings: 7096's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 7096's revenue (26.1% per year) is forecast to grow faster than the JP market (4.3% per year).
High Growth Revenue: 7096's revenue (26.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7096's Return on Equity is forecast to be high in 3 years time (25.5%)